Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Cerebellar Atrophy Associated With Gait Abnormalities in Older Adult Fallers
Aging, Dementia, and Behavioral Neurology
P2 - Poster Session 2 (8:00 AM-9:00 AM)
10-001

To investigate cerebellar lobule atrophy patterns in elderly fallers (EFs) and their association with gait and cognitive performance.

Cognitive impairments, gait, and balance deficits are major risk factors for falls in older adults, however, their neural fingerprints remain poorly understood. Recent neuroimaging evidence highlight the role of the cerebellum in both sensorimotor, and cognitive brain networks, suggesting that it may play a role in fall risk.

N=14 EF (mean age ± SD = 78 ± 1.5 yrs; > 2 falls in the past 6 months), and 20 healthy controls (HCs) (mean age ± SD = 69.6 ± 1.3 yrs) underwent a 3 T MRI scan obtaining 3D T1-weighted images, cognitive, and gait assessments. Cerebellar lobules segmentation was performed using the CERES pipeline, and were adjusted for intra-cranial volume. The relationship between the segmented volumes, gait, and cognitive performance scores was assessed using hierarchical multiple linear regression adjusting for age and gender. 

EFs exhibited lower, yet not significant, cerebellar volumes in lobule VI, Crus II, lobule VIIB, and lobule X compared to HCs. No significant differences were detected between both groups in gait speed, and stride length during both usual-and-dual task walking (p>0.05). Compared to HCs, EFs showed lower MOCA scores (p=0.004), and Color Trails Making Test part b (TMTb) scores (p=0.028). In this group, regression analysis showed that cerebellar metrics accounted for extra variance in both motor and cognitive performance, where lobule VI, VIIB, X, and Crus II volumes being independent predictors for normal walking stride length, dual-task gait speed, TMTb, and TMTb respectively (p < 0.05). No significant associations between cerebellar lobule volumes, and performance scores were observed in HCs.

The observed patterns of cerebellar lobule atrophy and their associations with motor and cognitive performance might allude to cerebellar involvement in the pathophysiology of falls in older adults. 

Authors/Disclosures

PRESENTER
No disclosure on file
No disclosure on file
Inbal Maidan, PhD (Tel aviv sourasky medical center) Dr. Maidan has nothing to disclose.
Nir Giladi, MD, FÂé¶¹´«Ã½Ó³»­ (Tel-Aviv Medical Center) Dr. Giladi has received personal compensation in the range of $0-$499 for serving as a Consultant for Sionara. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDerm. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharma2B. Dr. Giladi has stock in Vibrant. Dr. Giladi has stock in Lysosomal Therapeutics . The institution of Dr. Giladi has received research support from The Michael J Fox Foundation. The institution of Dr. Giladi has received research support from The National Parkinson Foundation. The institution of Dr. Giladi has received research support from The European Union . The institution of Dr. Giladi has received research support from The Israel Science Foundation. The institution of Dr. Giladi has received research support from Biogen . The institution of Dr. Giladi has received research support from Ionis. The institution of Dr. Giladi has received research support from Sieratzki Family Foundation . The institution of Dr. Giladi has received research support from The Aufzien Academic Center in Tel-Aviv University.
No disclosure on file
Anat Mirelman Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie . Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. The institution of Anat Mirelman has received research support from Department of Defense. The institution of Anat Mirelman has received research support from MJFF. The institution of Anat Mirelman has received research support from JPND. The institution of Anat Mirelman has received research support from EU-Horizon 2020.